Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS)
落基山神经科学临床研究网络 (RMNNCS)
基本信息
- 批准号:8866484
- 负责人:
- 金额:$ 30.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectBehavior DisordersBehavioralCerebrovascular DisordersChildChildhoodClinicalClinical InvestigatorClinical ResearchClinical SciencesCognition DisordersCognitiveCollaborationsColoradoCommunitiesDiagnosisDiagnosticDiseaseDoctor of MedicineEpilepsyFacultyFoundationsHospitalsHumanImaging technologyIndividualInstitutesInstitutionKnowledgeMedicineMovement DisordersNeurologistNeurologyNeuromuscular DiseasesNeuropsychologyNeurosciencesNeurovirologyNewsletterPatientsPediatric HospitalsPediatric NeurologyPostdoctoral FellowRecruitment ActivityResearchResearch PersonnelSchoolsSpecialistTechnologyTimeTrainingTranslatingTranslational ResearchUniversitiesWorkbaseexperienceimprovedinsightmedical schoolsmeetingsmembermolecular imagingnervous system disorderneurogeneticsneuroimagingneuroimmunologyneuromuscularneurosurgerypatient advocacy grouppatient populationpediatric patientsprofessorprogramsresponseweb site
项目摘要
DESCRIPTION (provided by applicant): In response to RFA-NS-11-008, we are proposing to develop the Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS). This program will reside at the University Of Colorado School Of Medicine within the Departments of Adult and Child Neurology, and will be executed between three institutions: University of Colorado School of Medicine, University of Colorado Hospital and The Children's Hospital. The Program Director will be Dr. Timothy Vollmer, M.D., Professor of Neurology, with Co-Program Director Dr. Paul Levisohn M.D., Associate Professor of Child Neurology. Co-Investigators will include numerous faculty members with experience in human research in adult and child neurology neuroimaging, and neurosurgery. Co-investigators include specialists in the fields of Cerebrovascular Disease, Movement Disorders, Epilepsy, Behavioral/Cognitive Neurology, Neurogenetics, Neuroimmunology, Neuroopthalmology and Neuromuscular Disease in both adult and pediatric patients. In conjunction with the RMNNCS, we propose to develop the Rocky Mountain Alliance for Neuroscience Clinical Studies (RMANCS). This will be collaboration between the RMNNCS, community-based neurologists and community-based patient advocacy groups focused on neurological disease from throughout the Rocky Mountain region. This will further enhance RMNNCS' ability to reach rare patient populations for NEXT studies and lay the foundation for identifying new clinical research concepts for the NEXT Centers of Excellence.
描述(由申请人提供):为了回应 RFA-NS-11-008,我们提议开发落基山神经科学临床研究网络 (RMNNCS)。该项目将设在科罗拉多大学医学院成人和儿童神经病学系,并将在三个机构之间执行:科罗拉多大学医学院、科罗拉多大学医院和儿童医院。该项目主任将由神经病学教授 Timothy Vollmer 博士(医学博士)和联合项目主任 Paul Levisohn 博士(儿童神经病学副教授)组成。联合研究人员将包括许多在成人和儿童神经病学、神经影像学和神经外科领域具有人类研究经验的教员。 共同研究人员包括成人和儿童患者的脑血管疾病、运动障碍、癫痫、行为/认知神经学、神经遗传学、神经免疫学、神经眼科和神经肌肉疾病领域的专家。 我们建议与 RMNNCS 一起建立落基山神经科学临床研究联盟 (RMANCS)。这将是 RMNNCS、社区神经科医生和社区患者倡导团体之间的合作,重点关注整个落基山脉地区的神经系统疾病。这将进一步增强 RMNNCS 接触稀有患者群体进行 NEXT 研究的能力,并为 NEXT 卓越中心确定新的临床研究概念奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY A BENKE其他文献
TIMOTHY A BENKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY A BENKE', 18)}}的其他基金
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
科罗拉多大学落基山 NeuroNEXT (UNCOMON) 临床研究联盟。
- 批准号:
10744629 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
CDKL5 缺乏症临床试验准备的生物标志物和核心临床结果指标的多中心验证
- 批准号:
10569019 - 财政年份:2021
- 资助金额:
$ 30.6万 - 项目类别:
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
CDKL5 缺乏症临床试验准备的生物标志物和核心临床结果指标的多中心验证
- 批准号:
10338135 - 财政年份:2021
- 资助金额:
$ 30.6万 - 项目类别:
Exploratory determination of the role of L-type calcium channels in mediating abnormal plasticity and behavior after early life seizures
探索性测定 L 型钙通道在介导早期癫痫发作后异常可塑性和行为中的作用
- 批准号:
9454781 - 财政年份:2017
- 资助金额:
$ 30.6万 - 项目类别:
Colorado Neurological Sciences Academic Development Award (NSADA)
科罗拉多神经科学学术发展奖 (NSADA)
- 批准号:
8788338 - 财政年份:2015
- 资助金额:
$ 30.6万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8217756 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8533043 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8323875 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8909216 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
Molecular mechanisms linking early life seizures, autism and intellectual disabil
生命早期癫痫发作、自闭症和智力障碍之间的分子机制
- 批准号:
8722047 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




